1174620

Esperion — FEI 3012969684

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 29, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ann Arbor, MI (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)